Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Not yet recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&lookfor=%22ulcerative+colitis.%22&type=Subject&page=283
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&lookfor=%22ulcerative+colitis.%22&type=Subject&page=283
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&lookfor=%22ulcerative+colitis.%22&type=Subject&page=283
PubPharm (2.829)
2821
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects with Moderately to Severely Active Ulcerative Colitis - PURSUIT - Intravenous : A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects with Moderately to Severely Active Ulcerative Colitis - PURSUIT - Intravenous
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
2822
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis - PURSUIT Subcutaneous : A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis - PURSUIT Subcutaneous
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
2823
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subjects with Intravenous Steroid-Refractory Ulcerative Colitis : A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subjects with Intravenous Steroid-Refractory Ulcerative Colitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
2824
A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF AST-120 IN MILD TO MODERATELY ACTIVE CROHN’S PATIENTS WITH FISTULAS : A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF AST-120 IN MILD TO MODERATELY ACTIVE CROHN’S PATIENTS WITH FISTULAS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
2825
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subjects with Intravenous Steroid-Refractory Ulcerative Colitis : A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subjects with Intravenous Steroid-Refractory Ulcerative Colitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
2826
A phase III, randomized, multi-center, double-blind, parallel-group, placebo controlled study to evaluate the safety and efficacy of SPD476 (mesalazine) given twice daily (2.4g/day) versus SPD476 given as a single dose (4.8g/day) in subject with acute mild to moderate ulcerative colitis. : A phase III, randomized, multi-center, double-blind, parallel-group, placebo controlled study to evaluate the safety and efficacy of SPD476 (mesalazine) given twice daily (2.4g/day) versus SPD476 given as a single dose (4.8g/day) in subject with acute mild to moderate ulcerative colitis.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
2827
A Phase 2, Randomized, Double-blind, Multicenter, Dose-exploration Study of Visilizumab in Subjects with Intravenous Steroid-Refractory Ulcerative Colitis : A Phase 2, Randomized, Double-blind, Multicenter, Dose-exploration Study of Visilizumab in Subjects with Intravenous Steroid-Refractory Ulcerative Colitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
2828
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects with Moderately to Severely Active Ulcerative Colitis - PURSUIT - Intravenous : A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects with Moderately to Severely Active Ulcerative Colitis - PURSUIT - Intravenous
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
2829
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis - PURSUIT Subcutaneous : A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis - PURSUIT Subcutaneous
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
[1]
« Vorheriger
273
274
275
276
277
278
279
280
281
282
283
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Medienart
2.829
Aufsätze
2.829
E-Artikel
2.829
E-Ressourcen
Zeitschriftentitel
2.802
WHO International Clinical Trials Registry Plat...
27
ClinicalTrials.gov
Thema
2.829
610
Recruitment Status: Not yet recruiting
2.703
Study Type: Interventional
899
Phase: Phase 3
749
Phase: Phase 2
132
Medical Condition: Ulcerative colitis MedDRA ve...
114
Medical Condition: Ulcerative Colitis MedDRA ve...
89
Study Type: Observational
78
Medical Condition: Ulcerative Colitis MedDRA ve...
74
Medical Condition: Ulcerative colitis
66
Medical Condition: Ulcerative Colitis MedDRA ve...
64
Medical Condition: Ulcerative Colitis
61
Phase: Phase 4
56
Medical Condition: ulcerative colitis
52
Medical Condition: Ulcerative Colitis (UC) MedD...
44
Medical Condition: Moderately to Severely Activ...
36
Medical Condition: Moderate to Severe Ulcerativ...
32
Medical Condition: Ulcerative Colitis MedDRA ve...
30
Medical Condition: Moderately to severely activ...
30
Medical Condition: Ulcerative Colitis MedDRA ve...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.349
2020-
1.480
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.813
Englisch
10
Spanisch
4
Unbestimmt
2
Finnisch
Haven't found what you're looking for?
Wird geladen...